Furthermore, an interesting finding that KZ treatment increased cAMP level and inhibited Akt activity motivated us to investigate whether KZ is a potential inhibitor of cAMP-PDE and Akt is implicated in the inhibition of NSCLC. Here, AKT1 is linked to non-small cell lung carcinoma.